Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy

Kidney cancer is the 7th most prevalent form of cancer in the United States with the vast majority of cases being classified as renal cell carcinoma (RCC). Multiple targeted therapies have been developed to treat RCC, but efficacy and resistance remain a challenge. In recent years, the modulation of...

Full description

Bibliographic Details
Main Authors:	Trace M. Jones, Jennifer S. Carew, Steffan T. Nawrocki
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Cancers
Subjects:	renal cell carcinoma autophagy hydroxychloroquine chloroquine ROC-325
Online Access:	https://www.mdpi.com/2072-6694/12/5/1185

Similar Items

Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
by: Steffan T. Nawrocki, et al.
Published: (2020-10-01)

Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
by: Dash S, et al.
Published: (2016-02-01)

Targeting Autophagy in Breast Cancer
by: Stefania Cocco, et al.
Published: (2020-10-01)

Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity
by: Kristi L. Helke, et al.
Published: (2022-06-01)

Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis
by: Yi-Chia Lin, et al.
Published: (2017-05-01)

Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review
by: Samiha Mohsen, et al.
Published: (2022-03-01)

A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer
by: Amal Kamal Abdel-Aziz, et al.
Published: (2022-10-01)

Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
by: Britney Niemann, et al.
Published: (2022-11-01)

Autophagy Inhibitors Do Not Restore Peroxisomal Functions in Cells With the Most Common Peroxisome Biogenesis Defect
by: Femke C. C. Klouwer, et al.
Published: (2021-04-01)

Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights
by: Asokan Devarajan, et al.
Published: (2021-01-01)

Position statement from the Brazilian Society of Nephrology regarding chloroquine and hydroxychloroquine drug dose adjustment according to renal function
by: José A. Moura-Neto, et al.
Published: (2020-08-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01)

Chloroquine-Based Mitochondrial ATP Inhibitors
by: Zhiguo Wang, et al.
Published: (2023-01-01)

Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma
by: Zhaoming Lu, et al.
Published: (2021-05-01)

Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
by: Natalia I. Agalakova
Published: (2024-01-01)

Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus
by: Ning An, et al.
Published: (2017-11-01)

Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma
by: Wei Zhao, et al.
Published: (2022-08-01)

New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
by: Davide Gentile, et al.
Published: (2020-08-01)

Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
by: Archana Bhatia, et al.
Published: (2022-01-01)

A Subject Review on a Some Analytical Methods for the Determination of Chloroquine and Hydroxychloroquine Drugs
by: Ali Khalil Mahmood, et al.
Published: (2022-01-01)

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01)

Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
by: Kavous Shahsavarinia, et al.
Published: (2021-12-01)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
by: Carolina Pereira Fernandes, et al.
Published: (2022-01-01)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021-11-01)

An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
by: Stefano Celotto, et al.
Published: (2021-02-01)

Dual Inhibition of Autophagy and PI3K/AKT/MTOR Pathway as a Therapeutic Strategy in Head and Neck Squamous Cell Carcinoma
by: Monique Bernard, et al.
Published: (2020-08-01)

Autophagy and renal cell carcinoma: What do we know so far?
by: Radovanović Milan, et al.
Published: (2021-01-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
by: Muhammad Haroon Aftab, et al.
Published: (2024-01-01)

Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon
by: Elsa Ayo Bivigou, et al.
Published: (2022-06-01)

Synthesis and structure of new modified derivatives based on the quinine molecule and their biological activity
by: Mukusheva Gulim, et al.
Published: (2023-03-01)

Insights into the mechanisms of action of chloroquine and hydroxychloroquine and its use in COVID-19 for chemoprophylaxis
by: Monalisa Sahu, et al.
Published: (2021-01-01)

Knowledge-based assessment of polymorphism in crystal structures involving chloroquine and hydroxychloroquine
by: Samuel Tetteh
Published: (2022-01-01)

Retinal toxicity induced by antimalarial drugs: literature review and case report
by: Manuel Garza-Leon, et al.
Published: (2016-06-01)

Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19
by: Li-Yuan Wang, et al.
Published: (2020-07-01)

Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
by: Jarir At Thobari
Published: (2021-08-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Chloroquine Urea Derivatives: Synthesis and Antitumor Activity in Vitro
by: Pavić Kristina, et al.
Published: (2018-12-01)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
by: Michael Takla, et al.
Published: (2020-12-01)

Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
by: Tangtavorn N, et al.
Published: (2016-11-01)